Scientists hunt for clues in body fluids to predict liver failure outcomes
NCT ID NCT02833064
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This study aims to find biological markers in blood, urine, stool, and breath that can predict how patients with acute liver injury or failure will fare. Researchers will collect samples daily for up to seven days from 200 participants, and a small group will also undergo MRI scans. The goal is to better understand the disease and improve care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict complications and outcomes in liver failure, guiding better treatment decisions.
- What could go wrong
- This is an observational study, not a treatment trial. It may not identify clear biomarkers, and findings may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scans could uncover silent damage in liver patients awaiting transplant
- Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?
- Blood transfusion strategy could be refined for liver patients
- Liver's Post-Meal secrets could unlock new fatty liver treatments
- Can eating only during an 8-10 hour window help liver cancer patients?
- New drug zanzalintinib tested for advanced liver cancer